Ali Behbahani - 01 Jul 2024 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
ADAP
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
01 Jul 2024, 17:10:03 UTC
Previous filing
21 Jun 2024
Next filing
12 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +1,144,686 $0.000000 1,144,686 01 Jul 2024 Ordinary Shares 1,144,686 $0.1600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.13 based on an exchange rate of U.S.$1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.